[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340551-105":3,"doc-detail-340551-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","outcomes-in-intraductal-papillary-mucinous-neoplasm-derived-pancreatic-cancer-differ-from-panin-derived-pancreatic-cancer","Outcomes in intraductal papillary mucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancer","","Background and Aim: Intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic ductal adenocarcinoma (PDAC) management is commonly extrapolated from pancreatic intraepithelial neoplasia (PanIN)-derived PDAC guidelines, despite biological divergence and subtype heterogeneity. Methods: Consecutive upfront surgery patients with PanIN-derived and IPMN-derived PDAC (2000–2019) were retrospectively identified across international centers and analyzed using one-to-one propensity score matching. Overall survival was compared using Kaplan–Meier and log-rank tests, with multivariable Cox regression for hazard ratios. Results: Median overall survival was 23.0 versus 43.1 months for PanIN-derived versus IPMN-derived PDAC. PanIN-derived disease showed worse T-stage, CA19-9, grade, and nodal status; tubular IPMN-derived tumors also demonstrated poorer pathology and outcomes. After matching, IPMN-derived PDAC retained a survival advantage, whereas tubular and colloid subtypes showed similar survival after adjustment. Conclusions: PanIN-derived PDAC has worse survival than IPMN-derived PDAC, supporting distinct outcomes. Colloid IPMN-derived PDAC has comparable survival to tubular after risk adjustment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/outcomes-in-intraductal-papillary-mucinous-neoplasm-derived-pancreatic-cancer-differ-from-panin-derived-pancreatic-cancer/340551/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/outcomes-in-intraductal-papillary-mucinous-neoplasm-derived-pancreatic-cancer-differ-from-panin-derived-pancreatic-cancer/340551.png","ImageObject",300,407,{"name":42,"@type":43},"Clementine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",17,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study aim regarding IPMN- and PanIN-derived PDAC outcomes?","Question",{"text":63,"@type":64},"The study assessed whether outcomes for IPMN-derived PDAC differ from outcomes for PanIN-derived PDAC, given that management is often extrapolated despite biological divergence and subtype heterogeneity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patient groups constructed for comparison?",{"text":68,"@type":64},"Consecutive upfront surgery patients from international centers (2000–2019) with PanIN-derived and IPMN-derived PDAC were retrospectively identified, then one-to-one propensity score matching was used to form matched cohorts.",{"name":70,"@type":61,"acceptedAnswer":71},"Which origin had worse overall survival, and were tubular vs colloid outcomes different?",{"text":72,"@type":64},"PanIN-derived PDAC showed worse overall survival than IPMN-derived PDAC on multivariable analysis. After risk adjustment, colloid and tubular IPMN-derived cancers had similar survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340551,1790182406,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002",8,"doi:10.1111/jgh.16686  \nORIGINAL ARTICLE - GASTRO ENTER OLOGY (CLINICAL)  \nOutcomes in intraductal papillary m ucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancer  \nJoseph R. Habib, * ,†  Ingmar F. Rompen, * ,‡ Ammar A. Javed, * Mahip Grewal, * Benedict Kinny-Köster,‡ Paul C. M. Andel,† D. Brock Hewitt, * Greg D. Sacks, * Marc G. Besselink, §,¶ Hjalmar C. vanSantvoort,† Lois A. Daamen,†, ** Martin Loos,‡ Jin He,†† Markus W. Büchler,‡‡ Christopher L. Wolfgang * and  \nI. Quintus Molenaar†  \n*Department of Surgery, New York University Langone Health, New York, New York,††Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA; †Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St. Antonius Hospital Nieuwegein,**Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht, §Department of Surgery, Amsterdam UMC, location University of Amsterdam, ¶Cancer Center Amsterdam, Amsterdam, The Netherlands; ‡Heidelberg University Hospital, Heidelberg, Germany; ‡‡Champalimaud Foundation, Lisbon, Portugal  \nKey words  \ncolloid, intraductal papillary mucinous neoplasm, invasive IPMN, pancreatic cancer, pancreatic cyst, pancreatic neoplasms, tubular.  \nAccepted for publication 13 July 2024 .  \nCorrespondence  \nI. Quintus Molenaar, Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St. Antonius Hospital Nieuwegein, 3508 GA Utrecht, The Netherlands.  \nEmail: [i.q.molenaar@umcutrecht.nl](i.q.molenaar@umcutrecht.nl)  \nDeclaration of conflict of interest: There are no conﬂicts of interest for any of the authors. The corresponding author had full access to all data and take full responsibility for the veracity of the data and statistical analysis.  \nFinancial support: None.  \nAbstract  \nBackground and Aim: Intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic ductal adenocarcinoma (PDAC) management is generally extrapolated from pancreatic intraepithelial neoplasia (PanIN)-derived PDAC guidelines. However, these are biologically divergent, and heterogeneity further exists between tubular and colloid subtypes. Methods: Consecutive upfront surgery patients with PanIN-derived and IPMN-derived PDAC were retrospectively identiﬁed from international centers (2000–2019) . One-to-one propensity score matching for clinicopathologic factors generated three cohorts: IPMN-derived versus PanIN-derived PDAC, tubular IPMN-derived versus PanIN-derived PDAC, and tubular versus colloid IPMN-derived PDAC. Overall survival (OS) was compared using Kaplan–Meier and log-rank tests. Multivariable Cox regression determined corresponding hazard ratios (HR) and 95% conﬁdence intervals (95% CI) .  \nResults: The median OS (mOS) in 2350 PanIN-derived and 700 IPMN-derived PDAC patients was 23.0 and 43.1 months (P \u003C 0.001), respectively. PanIN-derived PDAC had worse T-stage, CA19-9, grade, and nodal status. Tubular subtype had worse T-stage, CA19-9, grade, nodal status, and R1 margins, with a mOS of 33.7 versus 94.1 months (P \u003C 0.001) in colloid. Matched (n = 495), PanIN-derived and IPMN-derived PDAC had mOSs of 30.6 and 42.8 months (P \u003C 0.001), respectively. In matched (n = 341) PanIN-derived and tubular IPMN-derived PDAC, mOS remained poorer (27.7 vs 37.4, P \u003C 0.001) . Matched tubular and colloid cancers (n = 112) had similar OS (P = 0.55) . On multivariable Cox regression, PanIN-derived PDAC was associated with worse OS than IPMN-derived (HR: 1.66, 95% CI: 1.44–1.90) and tubular IPMN-derived (HR: 1.53, 95% CI: 1.32–1.77) PDAC. Colloid and tubular subtype was not associated with OS (P = 0.16) .  \nConclusions: PanIN-derived PDAC has worse survival than IPMN-derived PDAC supporting distinct outcomes. Although more indolent, colloid IPMN-derived PDAC has similar survival to tubular after risk adjustment.  \nIntroduction  \nIncidence of pancreatic cancer continues to rise and will soon eclipse colorectal cancer as the seco","cbCaigswpHvqWKRP","https://ap.wps.com/l/cbCaigswpHvqWKRP","pdf",710131,7,"English","# Abstract\n## Background and Aim\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the study aim regarding IPMN- and PanIN-derived PDAC outcomes?\",\"answer\":\"The study assessed whether outcomes for IPMN-derived PDAC differ from outcomes for PanIN-derived PDAC, given that management is often extrapolated despite biological divergence and subtype heterogeneity.\"},{\"question\":\"How were patient groups constructed for comparison?\",\"answer\":\"Consecutive upfront surgery patients from international centers (2000–2019) with PanIN-derived and IPMN-derived PDAC were retrospectively identified, then one-to-one propensity score matching was used to form matched cohorts.\"},{\"question\":\"Which origin had worse overall survival, and were tubular vs colloid outcomes different?\",\"answer\":\"PanIN-derived PDAC showed worse overall survival than IPMN-derived PDAC on multivariable analysis. After risk adjustment, colloid and tubular IPMN-derived cancers had similar survival.\"}]","Outcomes in intraductal papillary mucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancer | PDF",1790037286,18,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/926705b20eb2ab53dea81e3963a58a3a.webp",983,1287,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8da9f28c57492e34bfe62c6ad5a0fc53.webp",982,1286,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1af77e7a5819738ae332cca05d9a120.webp",981,1284,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82252126067faa59e0516f2c191cf18d.webp",980,1283,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,144,147,152,155,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":92,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":148,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":131,"slug":162},19,"General","general"]